What Wall St. Knows About Ingredion Today.

Mid-cap Consumer Staples company Ingredion has logged a 5.7% change today on a trading volume of 116,451. The average volume for the stock is 412,629.

Ingredion Incorporated, together with its subsidiaries, produces and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa. Based in Westchester, United States the company has 11,700 full time employees and a market cap of $6,687,455,744. Ingredion currently offers its equity investors a dividend that yields 3.0% per year.

The company is now trading -16.9% away from its average analyst target price of $121.67 per share. The 6 analysts following the stock have set target prices ranging from $113.0 to $132.0, and on average give Ingredion a rating of buy.

Over the last 52 weeks, INGR stock has risen 9.0%, which amounts to a -6.0% difference compared to the S&P 500. The stock's 52 week high is $113.46 whereas its 52 week low is $89.54 per share. Based on Ingredion's average net margin growth of 0.2% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 8,216,000 582,000 7 16.67
2022 7,946,000 502,000 6 200.0
2021 6,894,000 125,000 2 -66.67
2020 5,987,000 354,000 6 -14.29
2019 6,209,000 424,000 7 0.0
2018 6,289,000 454,000 7
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS